Cambridge Respiratory Innovations (CRI) creates ground-breaking respiratory technologies. In December 2020 it received funding from BGF and Downing Ventures to fast track research and development of its award-winning N-Tidal device to help medical professionals diagnose and monitor respiratory conditions. The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing.
Member count: 11-50
Investors 1
Date | Name | Website |
01.04.2021 | BGF Ventur... | bgf.co.uk |